VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Novo Nordisk Launches Weight-Loss Drug Wegovy (Semaglutide) in South Africa
Novo Nordisk Launches Weight-Loss Drug Wegovy (Semaglutide) in South Africa
Aug 14, 2025 17:55 CST Updated 17:55
Share:
Novo Nordisk
Insulin Developer and Manufacturer
Gelonghui August 14 | Novo Nordisk announced the launch of the weight-loss product semaglutide (Wegovy) in South Africa.